Is MYX a bargain, page-2180

Agree DDD. Track record is poor. No guarantees
of approvals or profits on approvals as Pat has said.
Many approvals don’t warrant an announcement
because they are meaningless but they certainly used
drug approvals as a lure to keep stringing people along.
Just when a drug starts making money another gets
competition and wipes out profits. Myx is like a heavy
747 always flying on 1 to 2 engines with the prospect
that the same mechanic can get all 4 engines going
at some stage when they can get the right parts in.
There isn’t any stampede to buy into Myx. Wise longs
that are heavily under water will exit if Myx manages a
decent approval because Shorts will have to cover but
I suspect the bounce will be short lived as traders take a
hasty profit. Myx took a huge run up to $1.40+ last time
and came crashing back to earth with a huge thud. As
Rivkin used to say you don’t go broke making a profit.
Myx big on promises with an atrocious track record on
delivery. I certainly hope longs burnt by SR get another
opportunity to exit and don’t get caught buying on the way
up again and suffering further should E4 not be the silver
bullet everyone’s looking for. Myx is a classic lesson for
many retail share holders-beware of the Disallowed salesman
who is becoming very wealthy as he sells the next dream
to punters who are still living the Teva nightmare 4 years
on. Maybe he’ll get this one right but it’s only an OCP at
the end of the day. Hopefully some of the Yanks will have
some spare coins in their back pockets after paying all their
bills on welfare to afford SR’s yet to be determined price tag
on E4 should it get approval....